Talphera (TLPH) Restructuring Costs (2015)
Talphera's (TLPH) quarterly Restructuring Costs came in at $2000.0 in Q2 2015, down 99.73% quarter-over-quarter from $754000.0 in Q1 2015.
Talphera (TLPH) Restructuring Costs (2015) Analysis & Trends
Talphera's Restructuring Costs history runs 1 years deep, the most recent figure standing at $2000.0 for Q2 2015.
- On a quarterly basis, Restructuring Costs changed N/A year-over-year to $2000.0 in Q2 2015; TTM through Dec 2015 was $756000.0, a N/A change from a year earlier, with the FY2015 full-year figure at $756000.0, changed N/A from the prior year.
- Restructuring Costs eased to $2000.0 in Q2 2015 per TLPH's latest filing, from $754000.0 in the prior quarter.
- Across five years, Restructuring Costs topped out at $754000.0 in Q1 2015 and bottomed at $2000.0 in Q2 2015.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Haleon | 88.07 Bn | 86.20 Bn | - |
| 2 | Teva Pharmaceutical Industries | 35.75 Bn | 32.01 Bn | 1.97 Bn |
| 3 | Zoetis | 31.84 Bn | 29.90 Bn | 1.62 Bn |
| 4 | Takeda Pharmaceutical | 27.18 Bn | 23.12 Bn | 4.39 Bn |
| 5 | United Therapeutics | 23.09 Bn | 20.93 Bn | 648.10 Mn |
| 6 | RedHill Biopharma | 21.32 Bn | 21.32 Bn | - |
| 7 | Viatris | 19.96 Bn | 18.16 Bn | 1.16 Bn |
| 8 | Neurocrine Biosciences | 17.66 Bn | 16.34 Bn | 800.70 Mn |
| 9 | Elanco Animal Health | 12.44 Bn | 12.02 Bn | 785.00 Mn |
| 10 | Talphera | 94.61 Mn | 56.78 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2015 | 2,000.00 |
| Mar 31, 2015 | 754,000.00 |